Lv1
40 积分 2024-12-16 加入
MAIT Cell–Mediated Immune Mechanisms of Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting
3小时前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
25天前
已完结
Targeting B Cells and Plasma Cells in Glomerular Disease
25天前
已完结
Complement and Glomerular Diseases
25天前
已关闭
中国甲状腺疾病诊治指南——甲状腺功能亢进症
1个月前
已完结
Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis
1个月前
已完结
Is primary membranous nephropathy a complement mediated disease?
2个月前
已完结
Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy
2个月前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
3个月前
已完结
Granulomatous Interstitial Nephritis
5个月前
已完结
Preliminary Efficacy and Safety Data from the Phase 2 Trial of Riliprubart (SAR445088), a Humanized Monoclonal Antibody Targeting Complement C1s, in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (S15.008)
2个月前
已采纳
Surface chemical studies on SiC suspension in the presence of chitosan
10个月前
已采纳
Application of Protein-Based Films and Coatings for Food Packaging: A Review
10个月前
已采纳
PHOTOAGING EFFECTS ON POLYETHYLENE MICROPLASTICS: STRUCTURAL CHANGES AND CHLORPYRIFOS ADSORPTION
10个月前
已采纳
Clinical Effect of PRP with DPASB on Full-Thickness Rotator Cuff Tears and Its Role in VAS, SST, and Constant Scores of Patients
10个月前
已撤回
In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach
10个月前
已采纳
Chatbots or me? Consumers’ switching between human agents and conversational agents
10个月前
已采纳
Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study
10个月前
已采纳
Polymer nanoparticles (nanomedicine) for therapeutic applications
10个月前
已采纳
皖公网安备34019202002308
